142 results on '"Kuglik P"'
Search Results
2. Exome sequencing improves the molecular diagnostics of paediatric unexplained neurodevelopmental disorders
3. Nestin expression in the cell lines derived from glioblastoma multiforme
4. Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development
5. Novel familial IQSEC2 pathogenic sequence variant associated with neurodevelopmental disorders and epilepsy
6. Large-Scale Automated Hollow-Fiber Bioreactor Expansion of Umbilical Cord-Derived Human Mesenchymal Stromal Cells for Neurological Disorders
7. The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay
8. The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay
9. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
10. Expanding application of next generation sequencing in clinical laboratory
11. Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma
12. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
13. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
14. Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma
15. TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
16. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
17. Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques
18. Gain 1q21 Versus Velcade- and Thalidomide-Based Regimens: B228
19. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment
20. Vicia faba chromosome damage induced by low doses of gamma radiation
21. Novel de novo pathogenic variant in the GNAI1gene as a cause of severe disorders of intellectual development
22. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM)
23. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas
24. Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH
25. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
26. Report from the European myeloma network on interphase FISH in multiple myeloma and related disorders
27. TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
28. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
29. P-17 High resolution oligonucleotide array-CGH method for preimplantation genetic screening: preclinical validation and first clinical results
30. 8009 POSTER The Determination of the Gene Amplification for Human Telomerase (hTERC) in Cervical Intraepithelial Neoplasia and Cervical Carcinoma in the Czech Republic
31. 159 Selection and clinical relevance of monoallelic and biallelic TP53 defects in chronic lymphocytic leukemia
32. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation
33. B228 Gain 1q21 Versus Velcade- and Thalidomide-Based Regimens
34. P141 Do the “new drugs” antagonize the impact of unfavourable cytogenetic markers in multiple myeloma?
35. O58 Correlation between chromosomal aberrations and standard prognostic factors in patients with multiple myeloma undergoing autologous stem cell transplantation
36. O22 Genetic lesions in multiple myeloma: prognostic and predictive significance in the era of the new drugs
37. P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy
38. The optimization of sample treatment for spectral karyotyping with applications for human tumour cells
39. Characterization of p53 Abnormalities in CLL Patients in Relation to IGVH Mutation Status and Previous Treatment.
40. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
41. Monoallelic and biallelic inactivation of TP53gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
42. Identification of 2.3-Mb Gene Locus for Congenital Aural Atresia in 18q22.3 Deletion
43. A607 Clinical Implication of Hyperdiploidy/Non-Hyperdiploidy in MM Patients Treated by Newer Drugs
44. Vicia fabachromosome damage induced by low doses of gamma radiation
45. GENE COPY NUMBER CHANGES IN MYELODYSPLASTIC SYNDROMES
46. MOLECULAR CYTOGENETIC STUDY OF IMMUNOFLUORESCENTLY LABELED PLASMA CELLS AND PROGNOSTIC SIGNIFICANCE OF CLONAL CHROMOSOMAL ABERRATIONS IN 208 PATIENS WITH MULTIPLE MYELOMA
47. Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-based array-comparative genomic hybridization in human myeloma cell line
48. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells
49. Autologous transplantation using interleukin 2 activated peripheral blood stem cell graft in chronical myeloid leukemia patients,Autologni transplantace s podanim interleukinem 2 aktivovaneho stepu perifernich kmenovych buniek nemocnym s chronickou myeloidni leukemii
50. GAIN/AMPLIFICATION OF 1Q21 IS THE MOST POWERFUL GENETIC PROGNOSTIC FACTOR FOR PATIENTS TREATED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.